Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophilia.
Rentz A, Flood E, Altisent C, Bullinger M, Klamroth R, Garrido RP, Scharrer I, Schramm W, Gorina E; Members of the HAEMO-QoL-A Steering Committee. Rentz A, et al. Among authors: schramm w. Haemophilia. 2008 Sep;14(5):1023-34. doi: 10.1111/j.1365-2516.2008.01812.x. Epub 2008 Jul 28. Haemophilia. 2008. PMID: 18665853
Haemophilia care in Europe: the ESCHQoL study.
Schramm W, Gringeri A, Ljung R, Berger K, Crispin A, Bullinger M, Giangrande PL, Von Mackensen S, Mantovani LG, Nemes L, Serban M; ESCHQOL Study Group. Schramm W, et al. Haemophilia. 2012 Sep;18(5):729-37. doi: 10.1111/j.1365-2516.2012.02847.x. Epub 2012 May 29. Haemophilia. 2012. PMID: 22639833
Outcome measures in haemophilia: more than just factor levels.
Bohn RL, Schramm W, Bullinger M, van den Berg M, Blanchette V. Bohn RL, et al. Among authors: schramm w. Haemophilia. 2004 Mar;10 Suppl 1:2-8. doi: 10.1111/j.1355-0691.2004.00873.x. Haemophilia. 2004. PMID: 14987243 Review. No abstract available.
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria.
Pollmann H, Externest D, Ganser A, Eifrig B, Kreuz W, Lenk H, Pabinger I, Schramm W, Schwarz TF, Zimmermann R, Zavazava N, Oldenburg J, Klamroth R. Pollmann H, et al. Among authors: schramm w. Haemophilia. 2007 Mar;13(2):131-43. doi: 10.1111/j.1365-2516.2006.01416.x. Haemophilia. 2007. PMID: 17286765
The economics of haemophilia prophylaxis: governmental and insurer perspectives. Proceedings of the Second International Prophylaxis Study Group (IPSG) symposium.
Feldman BM, Aledort L, Bullinger M, Delaney FM, Doria AS, Funk S, Giangrande P, Lundin B, Manco-Johnson M, Miners A, Scriba PC, Srivastava A, Schramm W, Blanchette VS; Second International Prophylaxis Study Group. Feldman BM, et al. Among authors: schramm w. Haemophilia. 2007 Nov;13(6):745-9. doi: 10.1111/j.1365-2516.2007.01542.x. Epub 2007 Sep 10. Haemophilia. 2007. PMID: 17850325 No abstract available.
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
Gringeri A, Leissinger C, Cortesi PA, Jo H, Fusco F, Riva S, Antmen B, Berntorp E, Biasoli C, Carpenter S, Kavakli K, Morfini M, Négrier C, Rocino A, Schramm W, Windyga J, Zülfikar B, Mantovani LG. Gringeri A, et al. Among authors: schramm w. Haemophilia. 2013 Sep;19(5):736-43. doi: 10.1111/hae.12178. Epub 2013 Jun 4. Haemophilia. 2013. PMID: 23731246 Clinical Trial.
412 results